Trastuzumab Cures Cancer and Disrupts the Practice of Cardiology

por Steingart, Richard M., Yu, Anthony F., Dang, Chau T.
Publicado 2019

A giant isolated primary splenic hydatidosis: A case report

por Sah, Rajan Kumar, Sah, Biki Kumar, Dang, Chau Thi Minh, Sah, Vivek Kumar
Publicado 2022

TIPS-10 FEASIBILITY OF A MULTI-MODALITY CENTRAL NERVOUS SYSTEM SCREENING EVALUATION IN HER2+ BREASTCANCER PATIENTS

por Malani, Rachna, Seidman, Andrew, Dang, Chau, Panageas, Katherine, Young, Robert, Boire, Adrienne, Wilcox, Jessica
Publicado 2023

SDPS-46 CENTRAL NERVOUS SYSTEM (CNS)-RELATED MORTALITY IN PATIENTS WITH HER2-POSITIVE METASTATIC BREAST CANCER

por Ferraro, Emanuela, Nassif, Rabih Bou, Reiner, Anne, Tosi, Umberto, Panageas, Katherine, Dang, Chau T, Seidman, Andrew D, Moss, Nelson
Publicado 2023

Evolving perspectives on the treatment of HR+/HER2+ metastatic breast cancer

por Pegram, Mark, Pietras, Richard, Dang, Chau T., Murthy, Rashmi, Bachelot, Thomas, Janni, Wolfgang, Sharma, Priyanka, Hamilton, Erika, Saura, Cristina
Publicado 2023

Real-World First-Line Use of Pertuzumab With Different Taxanes for Human Epidermal Growth Factor Receptor 2–Positive Metastatic Breast Cancer: A Comparative Effectiveness Study Usi...

por Polito, Letizia, Shim, Jinjoo, Hurvitz, Sara A., Dang, Chau T., Knott, Adam, Du Toit, Yolande, Restuccia, Eleonora, Sanglier, Thibaut, Swain, Sandra M.
Publicado 2023

Cardiotoxicity Surveillance and Risk of Heart Failure During HER2 Targeted Therapy

por Yu, Anthony F., Moskowitz, Chaya S., Lee Chuy, Katherine, Yang, Ji, Dang, Chau T., Liu, Jennifer E., Oeffinger, Kevin C., Steingart, Richard M.
Publicado 2020

Inflammatory cytokines and distant recurrence in HER2-negative early breast cancer

por Sparano, Joseph A., O’Neill, Anne, Graham, Noah, Northfelt, Donald W., Dang, Chau T., Wolff, Antonio C., Sledge, George W., Miller, Kathy D.
Publicado 2022

Rationale and design of a cardiac safety study for reduced cardiotoxicity surveillance during HER2-targeted therapy

por Yu, Anthony F., Dang, Chau T., Jorgensen, Justine, Moskowitz, Chaya S., DeFusco, Patricia, Oligino, Eric, Oeffinger, Kevin C., Liu, Jennifer E., Steingart, Richard M.
Publicado 2023

Pruritus Related to Trastuzumab and Pertuzumab in HER2+ Breast Cancer Patients

por Gu, Stephanie, Dusza, Stephen, Quigley, Elizabeth, Haliasos, Helen, Markova, Alina, Marchetti, Michael, Moy, Andrea, Dang, Chau, Modi, Shanu, Lake, Diana, Noor, Sarah, Lacouture, Mario
Publicado 2023

Quality of Life Following Receipt of Adjuvant Chemotherapy With and Without Bevacizumab in Patients With Lymph Node–Positive and High-Risk Lymph Node–Negative Breast Cancer

por Rosenberg, Shoshana M., O’Neill, Anne, Sepucha, Karen, Miller, Kathy D., Dang, Chau T., Northfelt, Donald W., Sledge, George W., Schneider, Bryan P., Partridge, Ann H.
Publicado 2022

Cardiac Safety of Paclitaxel Plus Trastuzumab and Pertuzumab in Patients With HER2-Positive Metastatic Breast Cancer

por Yu, Anthony F., Manrique, Carlos, Pun, Shawn, Liu, Jennifer E., Mara, Elton, Fleisher, Martin, Patil, Sujata, Jones, Lee W., Steingart, Richard M., Hudis, Clifford A., Dang, Chau T.
Publicado 2016

Impact of Diagnostic Delay on Disease Course in Pediatric- versus Adult-Onset Patients with Ulcerative Colitis: Data from the Swiss IBD Cohort

por Schoepfer, Alain M., Tran, Vu Dang Chau, Rossel, Jean-Benoit, Sokollik, Christiane, Spalinger, Johannes, Safroneeva, Ekaterina, von Graffenried, Thea, Godat, Sébastien, Hahnloser, Dieter, Vavricka, Stephan R., Braegger, Christian, Nydegger, Andreas
Publicado 2021

Intranasal Treatment of Ferrets with Inert Bacterial Spores Reduces Disease Caused by a Challenging H7N9 Avian Influenza Virus

por James, Joe, Meyer, Stephanie M., Hong, Huynh A., Dang, Chau, Linh, Ho T. Y., Ferreira, William, Katsande, Paidamoyo M., Vo, Linh, Hynes, Daniel, Love, William, Banyard, Ashley C., Cutting, Simon M.
Publicado 2022

Event-Free Survival in Patients with Early HER2-Positive Breast Cancer with a Pathological Complete Response after HER2-Targeted Therapy: A Pooled Analysis

por Swain, Sandra M., Macharia, Harrison, Cortes, Javier, Dang, Chau, Gianni, Luca, Hurvitz, Sara A., Jackisch, Christian, Schneeweiss, Andreas, Slamon, Dennis, Valagussa, Pinuccia, du Toit, Yolande, Heinzmann, Dominik, Knott, Adam, Song, Chunyan, Cortazar, Patricia
Publicado 2022

BERENICE Final Analysis: Cardiac Safety Study of Neoadjuvant Pertuzumab, Trastuzumab, and Chemotherapy Followed by Adjuvant Pertuzumab and Trastuzumab in HER2-Positive Early Breast...

por Dang, Chau, Ewer, Michael S., Delaloge, Suzette, Ferrero, Jean-Marc, Colomer, Ramon, de la Cruz-Merino, Luis, Werner, Theresa L., Dadswell, Katherine, Verrill, Mark, Eiger, Daniel, Sarkar, Sriparna, de Haas, Sanne Lysbet, Restuccia, Eleonora, Swain, Sandra M.
Publicado 2022

Incidence of brain metastases in patients with early HER2-positive breast cancer receiving neoadjuvant chemotherapy with trastuzumab and pertuzumab

por Ferraro, Emanuela, Singh, Jasmeet, Patil, Sujata, Razavi, Pedram, Modi, Shanu, Chandarlapaty, Sarat, Barrio, Andrea V., Malani, Rachna, Mellinghoff, Ingo K., Boire, Adrienne, Wen, Hannah Y., Brogi, Edi, Seidman, Andrew D., Norton, Larry, Robson, Mark E., Dang, Chau T.
Publicado 2022

Treatment discontinuation, patient-reported toxicities and quality-of-life by age following trastuzumab emtansine or paclitaxel/trastuzumab (ATEMPT)

por Sella, Tal, Zheng, Yue, Tayob, Nabihah, Ruddy, Kathryn J., Freedman, Rachel A., Dang, Chau, Yardley, Denise, Isakoff, Steven J., Valero, Vicente, DeMeo, Michelle, Burstein, Harold J., Winer, Eric P., Wolff, Antonio C., Krop, Ian, Partridge, Ann H., Tolaney, Sara M.
Publicado 2022

Efficacy and Safety of Gemcitabine With Trastuzumab and Pertuzumab After Prior Pertuzumab-Based Therapy Among Patients With Human Epidermal Growth Factor Receptor 2–Positive Metast...

por Iyengar, Neil M., Smyth, Lillian M., Lake, Diana, Gucalp, Ayca, Singh, Jasmeet C., Traina, Tiffany A., DeFusco, Patricia, Fornier, Monica N., Goldfarb, Shari, Jhaveri, Komal, Modi, Shanu, Troso-Sandoval, Tiffany, Patil, Sujata, Ulaner, Gary A., Jochelson, Maxine, Norton, Larry, Hudis, Clifford A., Dang, Chau T.
Publicado 2019

Innate immune signaling drives late cardiac toxicity following DNA-damaging cancer therapies

por Shamseddine, Achraf, Patel, Suchit H., Chavez, Valery, Moore, Zachary R., Adnan, Mutayyaba, Di Bona, Melody, Li, Jun, Dang, Chau T., Ramanathan, Lakshmi V., Oeffinger, Kevin C., Liu, Jennifer E., Steingart, Richard M., Piersigilli, Alessandra, Socci, Nicholas D., Chan, Angel T., Yu, Anthony F., Bakhoum, Samuel F., Schmitt, Adam M.
Publicado 2022